Three proteins (C1QTNF1, FGF-21 and CST3) were associated with incident HF among patients without bariatric surgery who retained excess body fat, suggesting that dyslipidemia and chronic kidney disease may constitute therapeutic targets to prevent the development of HF among patients with obesity. The gene discussed is CST3; the disease is obesity disorder.